MiR-155 is involved in Alzheimer's disease by regulating T lymphocyte function

Frontiers in Aging Neuroscience

Volumn 7, Issue APR, 2015, Pages

  Song, Juhyun ^a   Lee, Jong Eun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Alzheimer's disease (AD); immunity; Micro RNA 155 (miR 155); T lymphocyte (T cell)

Indexed keywords

CYTOKINE; MICRORNA 155;

ALZHEIMER DISEASE; CD8+ T LYMPHOCYTE; CELL FUNCTION; GLIA CELL; HUMAN; IMMUNE RESPONSE; MACROPHAGE; NERVE CELL; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; SHORT SURVEY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 84928784963     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00061     Document Type: Review

References (126)

1. Acunzo, M., Romano, G., Wernicke, D., and Croce, C. M. (2014). MicroRNA and cancer-a brief overview. Adv. Biol. Regul. 57, 1-9. doi: 10.1016/j.jbior.2015.02.001
2. Aharoni, R., Arnon, R., and Eilam, R. (2005). Neurogenesis and neuroprotection induced by peripheral immunomodulatory treatment of experimental autoimmune encephalomyelitis. J. Neurosci. 25, 8217-8228. doi: 10.1523/jneurosci.1859-05.2005
3. Aloisi, F., De Simone, R., Columba-Cabezas, S., Penna, G., and Adorini, L. (2000). Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J. Immunol. 164, 1705-1712. doi: 10.4049/jimmunol.164.4.1705
4. Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R., et al. (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122, 553-563. doi: 10.1016/j.cell.2005.07.031
5. Banerjee, A., Schambach, F., DeJong, C. S., Hammond, S. M., and Reiner, S. L. (2010). Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. Eur. J. Immunol. 40, 225-231. doi: 10.1002/eji.200939381
6. Barbato, C., Arisi, I., Frizzo, M. E., Brandi, R., Da Sacco, L., and Masotti, A. (2009). Computational challenges in miRNA target predictions: to be or not to be a true target? J. Biomed. Biotechnol. 2009:803069. doi: 10.1155/2009/803069
7. Baron, R., Nemirovsky, A., Harpaz, I., Cohen, H., Owens, T., and Monsonego, A. (2008). IFN-gamma enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J. 22, 2843-2852. doi: 10.1096/fj.08-105866
8. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism and function. Cell 116, 281-297. doi: 10.1016/S0092-8674(04)00045-5
9. Bartel, F., Pinkert, D., Fiedler, W., Kappler, M., Würl, P., Schmidt, H., et al. (2004). Expression of alternatively and aberrantly spliced transcripts of the MDM2 mRNA is not tumor-specific. Int. J. Oncol. 24, 143-151. doi: 10.3892/ijo.24.1.143
10. Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., et al. (1991). Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett. 285, 111-114. doi: 10.1016/0014-5793(91)80737-n
11. Baumjohann, D., and Ansel, K. M. (2013). MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat. Rev. Immunol. 13, 666-678. doi: 10.1038/nri3494
12. Britschgi, M., and Wyss-Coray, T. (2007). Systemic and acquired immune responses in Alzheimer's disease. Int. Rev. Neurobiol. 82, 205-233. doi: 10.1016/s0074-7742(07)82011-3
13. Browne, T. C., McQuillan, K., McManus, R. M., O'Reilly, J. A., Mills, K. H., and Lynch, M. A. (2013). IFN-gamma production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. J. Immunol. 190, 2241-2251. doi: 10.4049/jimmunol.1200947
14. Buck, A. H., Perot, J., Chisholm, M. A., Kumar, D. S., Tuddenham, L., Cognat, V., et al. (2010). Post-transcriptional regulation of miR-27 in murine cytomegalovirus infection. RNA 16, 307-315. doi: 10.1261/rna.1819210
15. Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., et al. (2006). Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci. U S A 103, 11784-11789. doi: 10.1073/pnas.0604681103
16. Cacabelos, R., and Torrellas, C. (2014). Epigenetic drug discovery for Alzheimer's disease. Expert Opin. Drug Discov. 9, 1059-1086. doi: 10.1517/17460441.2014.930124
17. Cacquevel, M., Lebeurrier, N., Chéenne, S., and Vivien, D. (2004). Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5, 529-534. doi: 10.2174/1389450043345308
18. Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., et al. (2001). In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467. doi: 10.1016/s0140-6736(01)05625-2
19. Calin, G. A., Liu, C. G., Sevignani, C., Ferracin, M., Felli, N., Dumitru, C. D., et al. (2004). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U S A 101, 11755-11760. doi: 10.1073/pnas.0404432101
20. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., et al. (2006). The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233. doi: 10.1038/ng1725
21. Chhabra, R., Adlakha, Y. K., Hariharan, M., Scaria, V., and Saini, N. (2009). Upregulation of miR-23a-27a-24-2 cluster induces caspase-dependent and -independent apoptosis in human embryonic kidney cells. PLoS One 4:e5848. doi: 10.1371/journal.pone.0005848
22. Cobb, B. S., Hertweck, A., Smith, J., O'Connor, E., Graf, D., Cook, T., et al. (2006). A role for Dicer in immune regulation. J. Exp. Med. 203, 2519-2527. doi: 10.1084/jem.20061692
23. Cogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., et al. (2008). Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
24. Culpan, D., Kehoe, P. G., and Love, S. (2011). Tumour necrosis factor-alpha (TNF-alpha) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-alpha on miRNA expression in vitro. Int. J. Mol. Epidemiol. Genet. 2, 156-162.
25. Di Bona, D., Plaia, A., Vasto, S., Cavallone, L., Lescai, F., Franceschi, C., et al. (2008). Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res. Rev. 59, 155-163. doi: 10.1016/j.brainresrev.2008.07.003
26. Di Bona, D., Vasto, S., Capurso, C., Christiansen, L., Deiana, L., Franceschi, C., et al. (2009). Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res. Rev. 8, 36-42. doi: 10.1016/j.arr.2008.09.001
27. Dudda, J. C., Salaun, B., Ji, Y., Palmer, D. C., Monnot, G. C., Merck, E., et al. (2013). MicroRNA-155 is required for effector CD8+ T cell responses to virus infection and cancer. Immunity 38, 742-753. doi: 10.1016/j.immuni.2012.12.006
28. Ethell, D. W., Shippy, D., Cao, C., Cracchiolo, J. R., Runfeldt, M., Blake, B., et al. (2006). Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol. Dis. 23, 351-361. doi: 10.1016/j.nbd.2006.03.008
29. Faraoni, I., Antonetti, F. R., Cardone, J., and Bonmassar, E. (2009). miR-155 gene: a typical multifunctional microRNA. Biochim. Biophys. Acta 1792, 497-505. doi: 10.1016/j.bbadis.2009.02.013
30. Filipowicz, W., Jaskiewicz, L., Kolb, F. A., and Pillai, R. S. (2005). Post-transcriptional gene silencing by siRNAs and miRNAs. Curr. Opin. Struct. Biol. 15, 331-341. doi: 10.1016/j.sbi.2005.05.006
31. Fillit, H., Ding, W. H., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., et al. (1991). Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci. Lett. 129, 318-320. doi: 10.1016/0304-3940(91)90490-k
32. Finch, C. E., and Morgan, T. E. (2007). Systemic inflammation, infection, ApoE alleles and Alzheimer disease: a position paper. Curr. Alzheimer Res. 4, 185-189. doi: 10.2174/156720507780362254
33. Fisher, Y., Nemirovsky, A., Baron, R., and Monsonego, A. (2010). T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease. PLoS One 5:e10830. doi: 10.1371/journal.pone.0010830
34. Foldes-Papp, Z., König, K., Studier, H., Bückle, R., Breunig, H. G., Uchugonova, A., et al. (2009). Trafficking of mature miRNA-122 into the nucleus of live liver cells. Curr. Pharm. Biotechnol. 10, 569-578. doi: 10.2174/138920109789069332
35. Galimberti, D., Villa, C., Fenoglio, C., Serpente, M., Ghezzi, L., Cioffi, S. M., et al. (2014). Circulating miRNAs as potential biomarkers in Alzheimer's disease. J. Alzheimers Dis. 42, 1261-1267. doi: 10.3233/JAD-140756
36. Gatto, G., Rossi, A., Rossi, D., Kroening, S., Bonatti, S., and Mallardo, M. (2008). Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic Acids Res. 36, 6608-6619. doi: 10.1093/nar/gkn666
37. Georgantas, R. W. 3rd, Hildreth, R., Morisot, S., Alder, J., Liu, C. G., Heimfeld, S., et al. (2007). CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc. Natl. Acad. Sci. U S A 104, 2750-2755. doi: 10.1073/pnas.0610983104
38. Gracias, D. T., Stelekati, E., Hope, J. L., Boesteanu, A. C., Doering, T. A., Norton, J., et al. (2013). The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nat. Immunol. 14, 593-602. doi: 10.1038/ni.2576
39. Gregory, R. I., and Shiekhattar, R. (2005). MicroRNA biogenesis and cancer. Cancer Res. 65, 3509-3512. doi: 10.1158/0008-5472.can-05-0298
40. Griffin, W. S., and Mrak, R. E. (2002). Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 72, 233-238.
41. Guedes, J. R., Custódia, C. M., Silva, R. J., de Almeida, L. P., Pedroso de Lima, M. C., and Cardoso, A. L. (2014). Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model. Hum. Mol. Genet. 23, 6286-6301. doi: 10.1093/hmg/ddu348
42. Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., et al. (2005). Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132. doi: 10.1038/ni1254
43. Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H., and Wekerle, H. (2006). The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. Neurol. Sci. 27(Suppl. 1), S1-S7. doi: 10.1007/s10072-006-0537-7
44. Huffaker, T. B., Hu, R., Runtsch, M. C., Bake, E., Chen, X., Zhao, J., et al. (2012). Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity. Cell Rep. 2, 1697-1709. doi: 10.1016/j.celrep.2012.10.025
45. Jindra, P. T., Bagley, J., Godwin, J. G., and Iacomini, J. (2010). Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. J. Immunol. 185, 990-997. doi: 10.4049/jimmunol.1000793
46. Johnson, C. D., Esquela-Kerscher, A., Stefani, G., Byrom, M., Kelnar, K., Ovcharenko, D., et al. (2007). The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713-7722. doi: 10.1158/0008-5472.can-07-1083
47. Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., et al. (2009). MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132, 3342-3352. doi: 10.1093/brain/awp300
48. Ke, Z. J., Bowen, W. M., and Gibson, G. E. (2006). Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolism. Neurochem. Int. 49, 548-556. doi: 10.1016/j.neuint.2006.04.011
49. Kim, V. N., and Nam, J. W. (2006). Genomics of microRNA. Trends Genet. 22, 165-173. doi: 10.1016/j.tig.2006.01.003
50. Kocerha, J., Faghihi, M. A., Lopez-Toledano, M. A., Huang, J., Ramsey, A. J., Caron, M. G., et al. (2009). MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc. Natl. Acad. Sci. U S A 106, 3507-3512. doi: 10.1073/pnas.0805854106
51. Kohlhaas, S., Garden, O. A., Scudamore, C., Turner, M., Okkenhaug, K., and Vigorito, E. (2009). Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J. Immunol. 182, 2578-2582. doi: 10.4049/jimmunol.0803162
52. Kopp, K. L., Ralfkiaer, U., Gjerdrum, L. M., Helvad, R., Pedersen, I. H., Litman, T., et al. (2013). STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell cycle 12, 1939-1947. doi: 10.4161/cc.24987
53. Korn, T., Bettelli, E., Gao, W., Awasthi, A., Jager, A., Strom, T. B., et al. (2007). IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448, 484-487. doi: 10.1038/nature05970
54. Lafaille, J. J. (1998). The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9, 139-151. doi: 10.1016/s1359-6101(98)00009-4
55. Lal, H., and Forster, M. J. (1988). Autoimmunity and age-associated cognitive decline. Neurobiol. Aging 9, 733-742. doi: 10.1016/s0197-4580(88)80141-6
56. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., et al. (2005). IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240. doi: 10.1084/jem.20041257
57. Larbi, A., Pawelec, G., Witkowski, J. M., Schipper, H. M., Derhovanessian, E., Goldeck, D., et al. (2009). Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease. J. Alzheimers Dis. 17, 91-103. doi: 10.3233/JAD-2009-1015
58. Lawrie, C. H., Soneji, S., Marafioti, T., Cooper, C. D., Palazzo, S., Paterson, J. C., et al. (2007). MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121, 1156-1161. doi: 10.1002/ijc.22800
59. Lee, Y. S., Nakahara, K., Pham, J. W., Kim, K., He, Z., Sontheimer, E. J., et al. (2004). Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell 117, 69-81. doi: 10.1016/S0092-8674(04)00261-2
60. Lind, E. F., Elford, A. R., and Ohashi, P. S. (2013). Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J. Immunol. 190, 1210-1216. doi: 10.4049/jimmunol.1202700
61. Lombardi, V. R., Fernández-Novoa, L., Etcheverria, I., Seoane, S., and Cacabelos, R. (2004). Association between APOE epsilon4 allele and increased expression of CD95 on T cells from patients with Alzheimer's disease. Methods Find. Exp. Clin. Pharmacol. 26, 523-529. doi: 10.1358/mf.2004.26.7.863735
62. Lombardi, V. R., Garcia, M., Rey, L., and Cacabelos, R. (1999). Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals. J. Neuroimmunol. 97, 163-171. doi: 10.1016/s0165-5728(99)00046-6
63. Lopez-Ramirez, M. A., Wu, D., Pryce, G., Simpson, J. E., Reijerkerk, A., King-Robson, J., et al. (2014). MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J. 28, 2551-2565. doi: 10.1096/fj.13-248880
64. Lu, L. F., Boldin, M. P., Chaudhry, A., Lin, L. L., Taganov, K. D., Hanada, T., et al. (2010). Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929. doi: 10.1016/j.cell.2010.08.012
65. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838. doi: 10.1038/nature03702
66. Lu, L. F., Thai, T. H., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., et al. (2009). Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91. doi: 10.1016/j.immuni.2008.11.010
67. Maegdefessel, L. (2014). The emerging role of microRNAs in cardiovascular disease. J. Intern. Med. 276, 633-644. doi: 10.1111/joim.12298
68. Man, S. M., Ma, Y. R., Shang, D. S., Zhao, W. D., Li, B., Guo, D. W., et al. (2007). Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer's disease. Neurobiol. Aging 28, 485-496. doi: 10.1016/j.neurobiolaging.2006.02.013
69. Martin, M. M., Lee, E. J., Buckenberger, J. A., Schmittgen, T. D., and Elton, T. S. (2006). MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J. Biol. Chem. 281, 18277-18284. doi: 10.1074/jbc.M601496200
70. Mastrangelo, M. A., Sudol, K. L., Narrow, W. C., and Bowers, W. J. (2009). Interferon-gamma differentially affects Alzheimer's disease pathologies and induces neurogenesis in triple transgenic-AD mice. Am. J. Pathol. 175, 2076-2088. doi: 10.2353/ajpath.2009.090059
71. Mattila, K. M., Pirttilä, T., Blennow, K., Wallin, A., Viitanen, M., and Frey, H. (1994). Altered blood-brain-barrier function in Alzheimer's disease? Acta Neurol. Scand. 89, 192-198. doi: 10.1111/j.1600-0404.1994.tb01660.x
72. McGeer, P. L., and McGeer, E. G. (2002). Innate immunity, local inflammation and degenerative disease. Sci. Aging Knowledge Environ. 2002:re3. doi: 10.1126/sageke.2002.29.re3
73. McQuillan, K., Lynch, M. A., and Mills, K. H. (2010). Activation of mixed glia by Abeta-specific Th1 and Th17 cells and its regulation by Th2 cells. Brain Behav. Immun. 24, 598-607. doi: 10.1016/j.bbi.2010.01.003
74. Miossec, P., Korn, T., and Kuchroo, V. K. (2009). Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361, 888-898. doi: 10.1056/NEJMra0707449
75. Monsonego, A., Imitola, J., Petrovic, S., Zota, V., Nemirovsky, A., Baron, R., et al. (2006). Abeta-induced meningoencephalitis is IFN-gamma-dependent and is associated with T cell-dependent clearance of Abeta in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U S A 103, 5048-5053. doi: 10.1073/pnas.0506209103
76. Monsonego, A., Imitola, J., Zota, V., Oida, T., and Weiner, H. L. (2003). Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells. J. Immunol. 171, 2216-2224. doi: 10.4049/jimmunol.171.5.2216
77. Murphy, A. C., Lalor, S. J., Lynch, M. A., and Mills, K. H. (2010). Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav. Immun. 24, 641-651. doi: 10.1016/j.bbi.2010.01.014
78. Nagelkerken, L. (1998). Role of Th1 and Th2 cells in autoimmune demyelinating disease. Braz. J. Med. Biol. Res. 31, 55-60. doi: 10.1590/s0100-879x1998000100007
79. Neilson, J. R., Zheng, G. X., Burge, C. B., and Sharp, P. A. (2007). Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 21, 578-589. doi: 10.1101/gad.1522907
80. Nelson, P. T., and Keller, J. N. (2007). RNA in brain disease: no longer just "the messenger in the middle". J. Neuropathol. Exp. Neurol. 66, 461-468. doi: 10.1097/01.jnen.0000240474.27791.f3
81. Nelson, P. T., Wang, W. X., and Rajeev, B. W. (2008). MicroRNAs (miRNAs) in neurodegenerative diseases. Brain Pathol. 18, 130-138. doi: 10.1111/j.1750-3639.2007.00120.x
82. O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., and Baltimore, D. (2009). Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. U S A 106, 7113-7118. doi: 10.1073/pnas.0902636106
83. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., et al. (2010). MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619. doi: 10.1016/j.immuni.2010.09.009
84. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., and Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. U S A 104, 1604-1609. doi: 10.1073/pnas.0610731104
85. Park, C. Y., Choi, Y. S., and McManus, M. T. (2010). Analysis of microRNA knockouts in mice. Hum. Mol. Genet. 19, R169-R175. doi: 10.1093/hmg/ddq367
86. Pellicano, M., Larbi, A., Goldeck, D., Colonna-Romano, G., Buffa, S., Bulati, M., et al. (2012). Immune profiling of Alzheimer patients. J. Neuroimmunol. 242, 52-59. doi: 10.1016/j.jneuroim.2011.11.005
87. Remarque, E. J., Bollen, E. L., Weverling-Rijnsburger, A. W., Laterveer, J. C., Blauw, G. J., and Westendorp, R. G. (2001). Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp. Gerontol. 36, 171-176. doi: 10.1016/s0531-5565(00)00176-5
88. Richartz-Salzburger, E., Batra, A., Stransky, E., Laske, C., Köhler, N., Bartels, M., et al. (2007). Altered lymphocyte distribution in Alzheimer's disease. J. Psychiatr. Res. 41, 174-178. doi: 10.1016/j.jpsychires.2006.01.010
89. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611. doi: 10.1126/science.1139253
90. Romero, P., Zippelius, A., Kurth, I., Pittet, M. J., Touvrey, C., Iancu, E. M., et al. (2007). Four functionally distinct populations of human effector-memory CD8+ T lymphocytes. J. Immunol. 178, 4112-4119. doi: 10.4049/jimmunol.178.7.4112
91. Rouas, R., Fayyad-Kazan, H., El Zein, N., Lewalle, P., Rothé, F., Simion, A., et al. (2009). Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur. J. Immunol. 39, 1608-1618. doi: 10.1002/eji.200838509
92. Rubio-Perez, J. M., and Morillas-Ruiz, J. M. (2012). A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal 2012:756357. doi: 10.1100/2012/756357
93. Rusca, N., Dehò, L., Montagner, S., Zielinski, C. E., Sica, A., Sallusto, F., et al. (2012). MiR-146a and NF-kappaB1 regulate mast cell survival and T lymphocyte differentiation. Mol. Cell. Biol. 32, 4432-4444. doi: 10.1128/mcb.00824-12
94. Salaun, B., Yamamoto, T., Badran, B., Tsunetsugu-Yokota, Y., Roux, A., Baitsch, L., et al. (2011). Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets. J. Transl. Med. 9:44. doi: 10.1186/1479-5876-9-44
95. Sardi, F., Fassina, L., Venturini, L., Inguscio, M., Guerriero, F., Rolfo, E., et al. (2011). Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun. Rev. 11, 149-153. doi: 10.1016/j.autrev.2011.09.005
96. Saresella, M., Calabrese, E., Marventano, I., Piancone, F., Gatti, A., Alberoni, M., et al. (2011). Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease. Brain Behav. Immun. 25, 539-547. doi: 10.1016/j.bbi.2010.12.004
97. Schindowski, K., Eckert, A., Peters, J., Gorriz, C., Schramm, U., Weinandi, T., et al. (2007). Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy. Neuromolecular Med. 9, 340-354. doi: 10.1007/s12017-007-8015-9
98. Schultz, J., Lorenz, P., Gross, G., Ibrahim, S., and Kunz, M. (2008). MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Res. 18, 549-557. doi: 10.1038/cr.2008.45
99. Skinner, J. P., Keown, A. A., and Chong, M. M. (2014). The miR-17 approximately 92a cluster of microRNAs is required for the fitness of Foxp3+ regulatory T cells. PLoS One 9:e88997. doi: 10.1371/journal.pone.0088997
100. Smigielska-Czepiel, K., van den Berg, A., Jellema, P., van der Lei, R. J., Bijzet, J., Kluiver, J., et al. (2014). Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun. 15, 115-125. doi: 10.1038/gene.2013.69
101. Sonkoly, E., Janson, P., Majuri, M. L., Savinko, T., Fyhrquist, N., Eidsmo, L., et al. (2010). MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J. Allergy Clin. Immunol. 126, 581.e1-589.e20. doi: 10.1016/j.jaci.2010.05.045
102. Speciale, L., Calabrese, E., Saresella, M., Tinelli, C., Mariani, C., Sanvito, L., et al. (2007). Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging 28, 1163-1169. doi: 10.1016/j.neurobiolaging.2006.05.020
103. Starr, T. K., Jameson, S. C., and Hogquist, K. A. (2003). Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139-176. doi: 10.1146/annurev.immunol.21.120601.141107
104. Steinman, L. (2006). State of the art. Four easy pieces: interconnections between tissue injury, intermediary metabolism, autoimmunity and chronic degeneration. Proc. Am. Thorac. Soc. 3, 484-486. doi: 10.1513/pats.200603-061ms
105. Strauss, S., Bauer, J., Ganter, U., Jonas, U., Berger, M., and Volk, B. (1992). Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66, 223-230.
106. Taganov, K. D., Boldin, M. P., Chang, K. J., and Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. U S A 103, 12481-12486. doi: 10.1073/pnas.0605298103
107. Tam, W. (2001). Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274, 157-167. doi: 10.1016/s0378-1119(01)00612-6
108. Tang, Q., and Bluestone, J. A. (2006). Regulatory T-cell physiology and application to treat autoimmunity. Immunol. Rev. 212, 217-237. doi: 10.1111/j.0105-2896.2006.00421.x
109. Tarasenko, T., Kole, H. K., Chi, A. W., Mentink-Kane, M. M., Wynn, T. A., and Bolland, S. (2007). T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc. Natl. Acad. Sci. U S A 104, 11382-11387. doi: 10.1073/pnas.0704853104
110. Tarkowski, E., Wallin, A., Regland, B., Blennow, K., and Tarkowski, A. (2001). Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol. Scand. 103, 166-174. doi: 10.1034/j.1600-0404.2001.103003166.x
111. Thai, T. H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., et al. (2007). Regulation of the germinal center response by microRNA-155. Science 316, 604-608. doi: 10.1126/science.1141229
112. Tili, E., Michaille, J. J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., et al. (2007). Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179, 5082-5089. doi: 10.4049/jimmunol.179.8.5082
113. Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., et al. (2002). Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124, 83-92. doi: 10.1016/s0165-5728(01)00496-9
114. Town, T., Tan, J., Flavell, R. A., and Mullan, M. (2005). T-cells in Alzheimer's disease. Neuromolecular Med. 7, 255-264. doi: 10.1385/NMM:7:3:255
115. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U S A 103, 2257-2261. doi: 10.1073/pnas.0510565103
116. Vugler, A., Lawrence, J., Walsh, J., Carr, A., Gias, C., Semo, M., et al. (2007). Embryonic stem cells and retinal repair. Mech. Dev. 124, 807-829. doi: 10.1016/j.mod.2007.08.002
117. Weiner, H. L., Lemere, C. A., Maron, R., Spooner, E. T., Grenfell, T. J., Mori, C., et al. (2000). Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann. Neurol. 48, 567-579. doi: 10.1002/1531-8249(200010)48:4<567::aid-ana3>3.3.co;2-n
118. Wimo, A., Jonsson, L., and Winblad, B. (2006). An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn. Disord. 21, 175-181. doi: 10.1159/000090733
119. Wolf, S. A., Steiner, B., Akpinarli, A., Kammertoens, T., Nassenstein, C., Braun, A., et al. (2009). CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 182, 3979-3984. doi: 10.4049/jimmunol.0801218
120. Wyss-Coray, T., Lin, C., Yan, F., Yu, G. Q., Rohde, M., McConlogue, L., et al. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618. doi: 10.1038/87945
121. Xu, W., and Li, J. Y. (2007). MicroRNA gene expression in malignant lymphoproliferative disorders. Chin. Med. J. (Engl) 120, 996-999.
122. Xue, S. R., Xu, D. H., Yang, X. X., and Dong, W. L. (2009). Alterations in lymphocyte subset patterns and co-stimulatory molecules in patients with Alzheimer disease. Chin. Med. J. (Engl) 122, 1469-1472.
123. Yang, L., Boldin, M. P., Yu, Y., Liu, C. S., Ea, C. K., Ramakrishnan, P., et al. (2012). miR-146a controls the resolution of T cell responses in mice. J. Exp. Med. 209, 1655-1670. doi: 10.1084/jem.20112218
124. Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., et al. (2008). MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82, 5295-5306. doi: 10.1128/jvi.02380-07
125. Yu, Y., Chai, J., Zhang, H., Chu, W., Liu, L., Ma, L., et al. (2014). miR-194 promotes burn-induced hyperglycemia via attenuating IGF-IR expression. Shock 42, 578-584. doi: 10.1097/SHK.0000000000000258
126. Zhang, N., and Bevan, M. J. (2010). Dicer controls CD8+ T-cell activation, migration and survival. Proc. Natl. Acad. Sci. U S A 107, 21629-21634. doi: 10.1073/pnas.1016299107